Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

A 33-year-old man presented to our dermatology clinic with a 1-month history of two painless ulcers on his right arm and ...

Spread This News Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe — ...

Shionogi & Co., Ltd. engages in the research ... a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

Early diagnosis is vital for HIV. The sooner you receive a blood test and diagnosis, the sooner you can start treatment to bring and keep HIV at undetectable levels. Staying in close contact with ...

Improving HIV Treatment in Children and Adolescents -- The Right Way July 18, 2024 — Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in ...

The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...

A HIV-positive care worker who was taken off the roster at a nursing home after disclosing her medical history to her employer has been awarded €22,500 for disability discrimination. The Workplace ...